Peroxisome proliferator-activated receptor alpha agonist attenuates oxidized-low density lipoprotein induced immune maturation of human monocyte-derived dendritic cells.
Shi
Hong-Yu
HY
Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Ge
Jun-Bo
JB
Fang
Wei-Yi
WY
Yao
Kang
K
Sun
Ai-Jun
AJ
Huang
Rong-Chong
RC
Jia
Qing-Zhe
QZ
Wang
Ke-Qiang
KQ
Zou
Yun-Zeng
YZ
Cao
Xue-Tao
XT
D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000187:drug effects* / Q000276:immunology; D004705:Endocytosis; D011345:Fenofibrate / Q000494:pharmacology*; D006801:Humans; D016130:Immunophenotyping; D008077:Lipoproteins, LDL / Q000633:toxicity*; D009000:Monocytes / Q000166:cytology*; D047493:PPAR alpha / Q000819:agonists* / Q000502:physiology
D016207:Cytokines; D008077:Lipoproteins, LDL; D047493:PPAR alpha; C099252:oxidized low density lipoprotein; D011345:Fenofibrate